Eric Adjei Boakye1, Nosayaba Osazuwa-Peters2,3, Kahee A Mohammed4, Sai Challapalli5, Paula Buchanan6, Thomas E Burroughs6, Mark A Varvares7. 1. Department of Population Science and Policy, Southern Illinois University School of Medicine, 201 E. Madison Street, P. O. Box 19664, Springfield, IL, 62794-9664, USA. eadjeiboakye49@siumed.edu. 2. Saint Louis University Cancer Center, 3655 Vista Ave, Third Floor, West Pavilion, St. Louis, MO, 63110, USA. 3. Department of Otolaryngology-Head and Neck Surgery, Saint Louis University School of Medicine, 3635 Vista Ave, 6th Floor Desloge Towers, St. Louis, MO, 63110, USA. 4. Department of Internal Medicine, Saint Louis University School of Medicine, 3635 Vista Ave, 12th Floor Desloge Towers, St. Louis, MO, 63110, USA. 5. Saint Louis University School of Medicine, 1402 S Grand Blvd, St. Louis, MO, 63104, USA. 6. Saint Louis University Center for Health Outcomes Research (SLUCOR), 3545 Lafayette Ave., 4th Floor, St. Louis, MO, 63104, USA. 7. Harvard Medical School, Department of Otolaryngology, The Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA, 02114, USA.
Abstract
PURPOSE: This study aimed to examine the factors associated with diagnosed depression among patients with a metastatic cancer. METHODS: We conducted a cross-sectional analysis of 39,223 hospital records from 2008 to 2013 National Inpatient Sample for patients with metastatic cancer. Diagnosed depression was defined using ICD-9-CM for major depression. Weighted, multivariable hierarchical regression model was used to examine the association between sociodemographic and clinical factors and depression among patients with a metastatic cancer. RESULTS: The prevalence of clinically diagnosed depression in patients with a metastatic cancer in our study sample was 7.3% (5.9% for males and 8.6% for females). The prevalence rate of diagnosed depression increased from 5.3 to 9.4% between 2008 and 2013. In multivariable analysis, patients were more likely to be diagnosed with depression if they were females (aOR = 1.44; 95% CI 1.25-1.66) compared to males; and had higher number of comorbidities (aOR = 1.11 per 1-unit increase in Elixhauser comorbidity score, 95% CI 1.07-1.15). In contrast, patients were less likely to be diagnosed with depression if they were blacks (aOR = 0.59; 95% CI 0.47-0.74) or other race (aOR = 0.58; 95% CI 0.47-0.72) compared with white patients. CONCLUSIONS: Women and individuals with more comorbidities were diagnosed with depression more frequently, whereas black patients were diagnosed less. Our findings could help providers to identify hospitalized patients with the higher risk of depression and screened patients with signs and symptoms of clinical depression.
PURPOSE: This study aimed to examine the factors associated with diagnosed depression among patients with a metastatic cancer. METHODS: We conducted a cross-sectional analysis of 39,223 hospital records from 2008 to 2013 National Inpatient Sample for patients with metastatic cancer. Diagnosed depression was defined using ICD-9-CM for major depression. Weighted, multivariable hierarchical regression model was used to examine the association between sociodemographic and clinical factors and depression among patients with a metastatic cancer. RESULTS: The prevalence of clinically diagnosed depression in patients with a metastatic cancer in our study sample was 7.3% (5.9% for males and 8.6% for females). The prevalence rate of diagnosed depression increased from 5.3 to 9.4% between 2008 and 2013. In multivariable analysis, patients were more likely to be diagnosed with depression if they were females (aOR = 1.44; 95% CI 1.25-1.66) compared to males; and had higher number of comorbidities (aOR = 1.11 per 1-unit increase in Elixhauser comorbidity score, 95% CI 1.07-1.15). In contrast, patients were less likely to be diagnosed with depression if they were blacks (aOR = 0.59; 95% CI 0.47-0.74) or other race (aOR = 0.58; 95% CI 0.47-0.72) compared with white patients. CONCLUSIONS:Women and individuals with more comorbidities were diagnosed with depression more frequently, whereas black patients were diagnosed less. Our findings could help providers to identify hospitalized patients with the higher risk of depression and screened patients with signs and symptoms of clinical depression.
Entities:
Keywords:
Depression; Hospitalized cancer patients; Metastatic cancer; National inpatient sample (NIS); Racial disparities
Authors: Robert E Roberts; Margarita Alegría; Catherine Ramsay Roberts; Irene Ger Chen Journal: J Behav Health Serv Res Date: 2005 Jan-Mar Impact factor: 1.505
Authors: Nosayaba Osazuwa-Peters; Matthew C Simpson; Longwen Zhao; Eric Adjei Boakye; Stephanie I Olomukoro; Teresa Deshields; Travis M Loux; Mark A Varvares; Mario Schootman Journal: Cancer Date: 2018-10-18 Impact factor: 6.860
Authors: Nosayaba Osazuwa-Peters; Matthew C Simpson; Rebecca L Rohde; Sai D Challapalli; Sean T Massa; Eric Adjei Boakye Journal: Cancer Control Date: 2021 Jan-Dec Impact factor: 3.302